These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29514145)

  • 21. Prognostic value of different biomarkers for cardiovascular death in unselected older patients in the emergency department.
    Bahrmann P; Christ M; Hofner B; Bahrmann A; Achenbach S; Sieber CC; Bertsch T
    Eur Heart J Acute Cardiovasc Care; 2016 Dec; 5(8):568-578. PubMed ID: 26483565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome.
    Zhang F; Li X; Ochs T; Chen L; Liao Y; Tang C; Jin H; Du J
    J Am Coll Cardiol; 2012 Jul; 60(4):315-20. PubMed ID: 22813609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Level of Mid-Regional Proadrenomedullin during ST-Segment Elevation Myocardial Infarction Is an Independent Predictor of Adverse Cardiac Events within 90-Day Follow-Up.
    Hartopo AB; Puspitawati I; Anggraeni VY
    Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association of midregional pro-adrenomedullin (MR-proADM) at ICU admission and fluid overload in patients post elective cardiac surgery.
    Pfortmueller CA; Ott I; Müller M; Wilson D; Schefold JC; Messmer AS
    Sci Rep; 2024 Sep; 14(1):20897. PubMed ID: 39245743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
    Tzikas S; Keller T; Ojeda FM; Zeller T; Wild PS; Lubos E; Kunde J; Baldus S; Bickel C; Lackner KJ; Münzel TF; Blankenberg S
    Heart; 2013 Mar; 99(6):388-95. PubMed ID: 23213173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
    Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
    Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stress markers predict mortality in patients with nonspecific complaints presenting to the emergency department and may be a useful risk stratification tool to support disposition planning.
    Nickel CH; Messmer AS; Geigy N; Misch F; Mueller B; Dusemund F; Hertel S; Hartmann O; Giersdorf S; Bingisser R
    Acad Emerg Med; 2013 Jul; 20(7):670-9. PubMed ID: 23859580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of 14 novel biomarkers in patients with acute chest pain and undetectable levels of conventional cardiac troponin.
    Meune C; Balmelli C; Twerenbold R; Reiter M; Reichlin T; Ziller R; Drexler B; Stelzig C; Freese M; Wolf C; Haaf P; Osswald S; Mueller C
    Int J Cardiol; 2013 Aug; 167(4):1164-9. PubMed ID: 22507551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perioperative Myocardial Injury After Noncardiac Surgery: Incidence, Mortality, and Characterization.
    Puelacher C; Lurati Buse G; Seeberger D; Sazgary L; Marbot S; Lampart A; Espinola J; Kindler C; Hammerer A; Seeberger E; Strebel I; Wildi K; Twerenbold R; du Fay de Lavallaz J; Steiner L; Gurke L; Breidthardt T; Rentsch K; Buser A; Gualandro DM; Osswald S; Mueller C;
    Circulation; 2018 Mar; 137(12):1221-1232. PubMed ID: 29203498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of mid-regional pro-adrenomedullin levels to cardiovascular and metabolic abnormalities, and mortality in an elderly population from the community.
    Eggers KM; Venge P; Lindahl B; Lind L
    Int J Cardiol; 2013 Oct; 168(4):3537-42. PubMed ID: 23722054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incremental Value of Preoperative Copeptin for Predicting Myocardial Injury.
    Mauermann E; Bolliger D; Seeberger E; Puelacher C; Corbiere S; Filipovic M; Seeberger M; Mueller C; Lurati Buse G
    Anesth Analg; 2016 Dec; 123(6):1363-1371. PubMed ID: 27870734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Midregional fragment of proadrenomedullin, new-onset albuminuria, and cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-30).
    Landman GW; van Dijk PR; Drion I; van Hateren KJ; Struck J; Groenier KH; Gans RO; Bilo HJ; Bakker SJ; Kleefstra N
    Diabetes Care; 2014; 37(3):839-45. PubMed ID: 24170764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mid-regional pro-adrenomedullin and lactate levels for risk stratification in patients with out-of-hospital cardiac arrest.
    Zelniker TA; Schwall D; Hamidi F; Steinbach S; Scheller P; Spaich S; Michels G; Giannitsis E; Katus HA; Frey N; Preusch MR
    Eur Heart J Acute Cardiovasc Care; 2023 Jun; 12(6):364-371. PubMed ID: 36943296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mid-region pro-adrenomedullin adds predictive value to clinical predictors and Framingham risk score for long-term mortality in stable outpatients with heart failure.
    Xue Y; Taub P; Iqbal N; Fard A; Clopton P; Maisel A
    Eur J Heart Fail; 2013 Dec; 15(12):1343-9. PubMed ID: 23887059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
    Morgenthaler NG; Struck J; Alonso C; Bergmann A
    Clin Chem; 2005 Oct; 51(10):1823-9. PubMed ID: 16099941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can mid-regional pro-adrenomedullin (MR-proADM) increase the prognostic accuracy of NEWS in predicting deterioration in patients admitted to hospital with mild to moderately severe illness? A prospective single-centre observational study.
    Graziadio S; O'Leary RA; Stocken DD; Power M; Allen AJ; Simpson AJ; Price DA
    BMJ Open; 2019 Feb; 8(11):e020337. PubMed ID: 30798282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease.
    Neumann JT; Tzikas S; Funke-Kaiser A; Wilde S; Appelbaum S; Keller T; Ojeda-Echevarria F; Zeller T; Zwiener I; Sinning CR; Jagodzinski A; Schnabel RB; Lackner KJ; Münzel T; Blankenberg S; Wild PS; Sydow K
    Atherosclerosis; 2013 Jun; 228(2):451-9. PubMed ID: 23562132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis.
    Palladini G; Barassi A; Perlini S; Milani P; Foli A; Russo P; Albertini R; Obici L; Lavatelli F; Sarais G; Casarini S; Moratti R; Melzi d'Eril GV; Merlini G
    Amyloid; 2011 Dec; 18(4):216-21. PubMed ID: 22070520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.
    Gordo-Remartínez S; Calderón-Moreno M; Fernández-Herranz J; Castuera-Gil A; Gallego-Alonso-Colmenares M; Puertas-López C; Nuevo-González JA; Sánchez-Sendín D; García-Gámiz M; Sevillano-Fernández JA; Álvarez-Sala LA; Andueza-Lillo JA; de Miguel-Yanes JM
    PLoS One; 2015; 10(6):e0125212. PubMed ID: 26030588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.